Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma (Q81919524)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 July 2005
edit
Language Label Description Also known as
English
Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma
scientific article published on 01 July 2005

    Statements

    Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit